NeuroMetrix Reports Recent Media Coverage for Quell

NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media attention focusing on the company's innovative Quell® Wearable Pain Relief Technology™. Highlights include:

• Forbes – Can this wearable device really zap away chronic pain?
• Huffington Post – Wearables: When “Too Good to Be True” Is No Longer True
• Wareable – Meet the wearables tackling pain relief
• Techlicious – Review of the Quell Wearable Pain Relief Device
• The Financial Exchange (WRKO) – Interview with Dr. Shai Gozani, CEO of NeuroMetrix
• Cable News - Coffee with America – Retired NFL Star Shares his experience with Quell
• Drug Store News – Electrotherapy devices dominate shelves & From ‘wearables to ther-ables’
• Diatribe - Quell Device to Treat Chronic Pain Wins SXSW “Best Wearable Technology” Award
• Chronic Pain Blogger Reviews including: Wear, Tear & Care, FibroDaze, Fed Up with Fatigue & Counting My Spoons

Recent press coverage has reached an estimated audience of over 100MM people and included overwhelmingly positive reviews from chronic pain sufferers who tried Quell. Blogger Jennifer Kilgore, of Wear, Tear and Care summarized her experience by writing, "The Quell pain relief device means I can live more of my life."

"We are excited that Quell continues to attract the attention of high profile media outlets,” said Frank McGillin, Senior Vice President and General Manager, Consumer. "The positive reviews in leading chronic pain blogs, reinforces the positive impact that Quell is making for people dealing with chronic pain."

About Quell Wearable Pain Relief Technology

Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device utilizes NeuroMetrix's patented technology to provide widespread pain relief. In a recent clinical study, Quell improved chronic pain in 81% of participants. Quell is currently available through select healthcare professionals, retailers and online at www.QuellRelief.com.

About NeuroMetrix

NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham, Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996. For more information, please visit www.NeuroMetrix.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160728006410/en/